Societe Generale is one of the leading financial services groups in Europe. Based on a diversified and integrated banking model, the Group combines financial solidity and a strategy of sustainable growth. Our objective: to be the leading relationship-focused bank, a reference in its markets, close to its clients and chosen for the quality and commitment of its teams.
Frédéric Oudéa Chief Executive Officer
What will truly make the difference is the commitment of our teams to serving our customers.
Societe Generale in brief
Societe Generale supports 31 million individuals, professionals, companies and institutional investors worldwide, placing Corporate Social Responsibility, innovation and digital technology at the heart of its activities to continuously enhance the client experience, advance the economy and contribute to development.
Societe Generale has published it’s very first Integrated Report. “Our intention is to provide explicit information on the Group’s performance in terms of its value creation model, working for the benefit of all its stakeholders. Societe Generale is about more than performance and results: at its heart is the commitment of its 147,000 members of staff, the men and women who work each day to build the world of tomorrow,” Lorenzo Bini Smaghi, Chairman of the Board of Directors, and Frédéric Oudéa, Chief Executive Officer.
Our values in the service of our customers
Meeting our customers’ needs as a trusted partner
In a changing world, we support all our clients while demonstrating true team spirit. A responsible and trusting partner, we provide attentiveness, agility and the complementary nature of our expertise.
We work with our clients the way we work with one another: by listening, building together, valuing contributions and being united in both our successes and our difficulties.
Anticipating the uses of the future
We strive to constantly improve our customer approach by leveraging technical innovation and working together to adapt our solutions and practices to the uses of the future.
True to our entrepreneurial esprit, we are changing our ways of working by promoting sharing, experimentation and out of the box thinking. We learn from successes and failures alike.
Contributing to the development of economies
Our responsibility and our corporate ethics consist in meeting our customers’ various needs while safeguarding the long-term interests of all our stakeholders.
Our responsibility can also be seen in our courage to be accountable for our actions and decisions and to express our opinions transparently. We attach as much importance to the way we achieve results as we do to the results themselves.
Contributing to the success of our clients
Our employees are fully committed to contributing to the success of our clients.
We promote involvement and professional accomplishment for all. We nurture relationships based on trust and mutual respect, both inside and outside the bank.
Our commitment derives from the continued satisfaction of our clients in our skills and expertise.
OUR COMMITMENT TO SERVING THE ECONOMY
1st corporate green bond ever in Germany
Wind energy has become one of the leading choices for green and environmentally friendly electricity generating capacity over the years and currently covers more than 10% of EU's electricity demand. The growth depends on onshore (wind power stations on land) and offshore (wind turbines in the open sea) wind farms. Especially offshore wind farms have gained traction, as they have become increasingly accepted by the public and the wind yield is higher, since winds are stronger and more consistent in the open sea.
Health, a priority for Senegal
Health has always been a primary concern of any population and remains a major challenge for developing countries today. In Senegal, significant efforts are being made to improve the supply and access to healthcare across the country. The government of Senegal has launched a vast programme called the "Plan Sénégal Emergent" (PSE), of which Societe Generale is a financial partner. As part of this programme, a financing contract for over €160 million has been signed for a project aimed at improving access to healthcare, with notably the construction of four new regional hospitals in the country.
Supporting the economy
Promising treatments for rare illnesses
Lysogene is a French biotech company created in 2009 by Karen Aiach and Olivier Danos. The company is a pioneer in the fundamental research and clinical development of gene therapies. Lysogene uses adeno-associated viral vectors to treat rare and fatal illnesses that affect the central nervous systems of children.